Aisha Elsharkawy

9.1k total citations
62 papers, 862 citations indexed

About

Aisha Elsharkawy is a scholar working on Epidemiology, Hepatology and Infectious Diseases. According to data from OpenAlex, Aisha Elsharkawy has authored 62 papers receiving a total of 862 indexed citations (citations by other indexed papers that have themselves been cited), including 53 papers in Epidemiology, 50 papers in Hepatology and 6 papers in Infectious Diseases. Recurrent topics in Aisha Elsharkawy's work include Liver Disease Diagnosis and Treatment (50 papers), Hepatitis C virus research (41 papers) and Hepatitis B Virus Studies (20 papers). Aisha Elsharkawy is often cited by papers focused on Liver Disease Diagnosis and Treatment (50 papers), Hepatitis C virus research (41 papers) and Hepatitis B Virus Studies (20 papers). Aisha Elsharkawy collaborates with scholars based in Egypt, United States and Fiji. Aisha Elsharkawy's co-authors include Gamal Esmat, Mohamed El‐Kassas, Imam Waked, Rabab Fouad, Asmaa Gomaa, Naglaa Allam, Shereen Abdel Alem, Maissa El Raziky, Wafaa Elakel and Tamer Elbaz and has published in prestigious journals such as SHILAP Revista de lepidopterología, Gut and Scientific Reports.

In The Last Decade

Aisha Elsharkawy

58 papers receiving 839 citations

Peers

Aisha Elsharkawy
Ioannis Goulis Greece
Ayman Yosry Egypt
Jacinta A. Holmes Australia
Maissa El Raziky Egypt
Jennifer E. Layden‐Almer United States
Xiaoguang Dou China
Eduardo B. Martins United States
Jaime Enríquez Spain
Ana de Lourdes Candolo Martinelli Brazil
O Inoue Japan
Ioannis Goulis Greece
Aisha Elsharkawy
Citations per year, relative to Aisha Elsharkawy Aisha Elsharkawy (= 1×) peers Ioannis Goulis

Countries citing papers authored by Aisha Elsharkawy

Since Specialization
Citations

This map shows the geographic impact of Aisha Elsharkawy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aisha Elsharkawy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aisha Elsharkawy more than expected).

Fields of papers citing papers by Aisha Elsharkawy

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aisha Elsharkawy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aisha Elsharkawy. The network helps show where Aisha Elsharkawy may publish in the future.

Co-authorship network of co-authors of Aisha Elsharkawy

This figure shows the co-authorship network connecting the top 25 collaborators of Aisha Elsharkawy. A scholar is included among the top collaborators of Aisha Elsharkawy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aisha Elsharkawy. Aisha Elsharkawy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
El‐Kassas, Mohamed, Wafaa Elakel, Aisha Elsharkawy, et al.. (2024). Comparison of different noninvasive scores for assessing hepatic fibrosis in a cohort of chronic hepatitis C patients. Scientific Reports. 14(1). 29544–29544. 1 indexed citations
3.
4.
Elsharkawy, Aisha, et al.. (2023). The implications of the COVID-19 pandemic on hepatitis B and C elimination programs in Egypt: current situation and future perspective. SHILAP Revista de lepidopterología. 13(1). 3 indexed citations
5.
Hashem, Mohamed, et al.. (2023). Performance of Albumin-Bilirubin (ALBI) score in comparison to other non-invasive markers in the staging of liver fibrosis in chronic HCV patients. SHILAP Revista de lepidopterología. 13(1). 1 indexed citations
6.
Yosry, Ayman, Naglaa Zayed, Reham M. Dawood, et al.. (2022). Highly Sensitive Serum miRNA Panel for the Diagnosis of Hepatocellular Carcinoma in Egyptian Patients with HCV-Related HCC. Laboratory Medicine. 53(5). 523–529. 6 indexed citations
7.
Elsharkawy, Aisha, et al.. (2022). Fibrosis regression following hepatitis C antiviral therapy. World Journal of Hepatology. 14(6). 1120–1130. 13 indexed citations
8.
Alem, Shereen Abdel, et al.. (2022). Incidence of hepatitis C virus infection among people living with HIV: An Egyptian cohort study. Southern African Journal of HIV Medicine. 23(1). 1442–1442. 2 indexed citations
9.
ElHefnawi, Mahmoud, et al.. (2021). The oral microbiome of treated and untreated chronic HCV infection: A preliminary study. Oral Diseases. 29(2). 843–852. 5 indexed citations
10.
Gamil, Mohamed, Mohamed Alboraie, Aisha Elsharkawy, et al.. (2018). Novel scores combining AFP with non‐invasive markers for prediction of liver fibrosis in chronic hepatitis C patients. Journal of Medical Virology. 90(6). 1080–1086. 23 indexed citations
11.
Raziky, Maissa El, et al.. (2018). Effect of Direct-Acting Agents on Fibrosis Regression in Chronic Hepatitis C Virus Patients' Treatment Compared with Interferon-Containing Regimens. Journal of Interferon & Cytokine Research. 38(3). 129–136. 10 indexed citations
12.
13.
Fouad, Rabab, et al.. (2017). Efficacy of carvedilol versus propranolol versus variceal band ligation for primary prevention of variceal bleeding. Hepatology International. 12(1). 75–82. 23 indexed citations
14.
Elsharkawy, Aisha, et al.. (2017). Impact of different sofosbuvir based treatment regimens on the biochemical profile of chronic hepatitis C genotype 4 patients. Expert Review of Gastroenterology & Hepatology. 11(8). 773–778. 30 indexed citations
15.
Gomaa, Asmaa, Naglaa Allam, Aisha Elsharkawy, Mohamed El‐Kassas, & Imam Waked. (2017). Hepatitis C infection in Egypt: prevalence, impact and management strategies. SHILAP Revista de lepidopterología. Volume 9. 17–25. 135 indexed citations
16.
Elsharkawy, Aisha, et al.. (2016). Noninvasive Assessment of Liver Fibrosis in Egyptian Children with Chronic Liver Diseases.. Current Pediatric Research. 20(1). 0. 9 indexed citations
17.
Raziky, Maissa El, et al.. (2015). IP-10 Serum Level in Chronic Hepatitis C Virus Patients: Relation to Fibrosis and Response to Combined Interferon/Ribavirin Therapy. Journal of Interferon & Cytokine Research. 35(8). 649–653. 7 indexed citations
18.
Esmat, Gamal, Maissa El Raziky, Aisha Elsharkawy, et al.. (2014). Impact of Vitamin D Supplementation on Sustained Virological Response in Chronic Hepatitis C Genotype 4 Patients Treated by Pegylated Interferon/Ribavirin. Journal of Interferon & Cytokine Research. 35(1). 49–54. 37 indexed citations
19.
Esmat, Gamal, Aisha Elsharkawy, Wafaa Elakel, et al.. (2013). Fibroscan of chronic HCV patients coinfected with schistosomiasis. Arab Journal of Gastroenterology. 14(3). 109–112. 15 indexed citations
20.
Raziky, Maissa El, Dina Attia, Wafaa Elakel, et al.. (2013). Hepatic fibrosis and serum alpha-fetoprotein (AFP) as predictors of response to HCV treatment and factors associated with serum AFP normalisation after treatment. Arab Journal of Gastroenterology. 14(3). 94–98. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ioannis Goulis Breakdown of academic impact, for papers by Ayman Yosry Breakdown of academic impact, for papers by Jacinta A. Holmes Breakdown of academic impact, for papers by Maissa El Raziky Breakdown of academic impact, for papers by Jennifer E. Layden‐Almer Breakdown of academic impact, for papers by Xiaoguang Dou Breakdown of academic impact, for papers by Eduardo B. Martins Breakdown of academic impact, for papers by Jaime Enríquez Breakdown of academic impact, for papers by Ana de Lourdes Candolo Martinelli Breakdown of academic impact, for papers by O Inoue
Rankless by CCL
2026